Clover Therapeutics' Biz Plan Competition Round

Clover Therapeutics raised a round of funding on July 21, 2017. Investors include Premio Gaetano Marzotto.

Clover Therapeutics is developing a technology platform based on drug delivery and biomimicry, whose first application will be in the urological oncology field, specifically against Bladder Cancer.…

Articles about Clover Therapeutics' Biz Plan Competition Round: